Fig. 3From: Pembrolizumab-induced myasthenia gravis-like disorder, ocular myositis, and hepatitis: a case reportGadolinium-enhanced T1-weighted MRI image showing no abnormal mass lesions or enhancement within the cavernous sinus, axial viewBack to article page